• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在GnRH拮抗剂周期中,卵巢刺激开始时的促性腺激素水平可预测hCG再次触发后的正常受精情况。

Gonadotropin levels at the start of ovarian stimulation predict normal fertilization after hCG re-trigger in GnRH antagonist cycles.

作者信息

Kitasaka Hiroya, Tokoro Mikiko, Kojima Masae, Fukunaga Noritaka, Asada Yoshimasa

机构信息

Asada Ladies Clinic Nagoya Japan.

Asada Institute for Reproductive Medicine Kasugai Japan.

出版信息

Reprod Med Biol. 2020 Dec 18;20(1):96-107. doi: 10.1002/rmb2.12359. eCollection 2021 Jan.

DOI:10.1002/rmb2.12359
PMID:33488289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7812458/
Abstract

PURPOSE

To assess the appropriateness of human chorionic gonadotropin (hCG) re-trigger in poor responders to gonadotropin-releasing hormone agonist (GnRHa) trigger in controlled ovarian stimulation (COS) cycles.

METHODS

The 2251 cycles in 2251 patients triggered with GnRHa for oocyte stimulation, with or without requiring hCG re-trigger between 2013 and 2018, were retrospectively analyzed to compare gonadotropin levels at the start of COS and the rate of normal fertilization between the re-trigger and non-re-trigger group. Furthermore, patients in the re-trigger group were stratified by the rate of normal fertilization (good: ≥60% or poor: <60%) to compare patient demographics, hormone profiles, and clinical outcome between the subgroups.

RESULTS

In the re-trigger group, FSH and LH levels at the start of COS were significantly lower in the good fertilization group than in the poor fertilization group ( < .01). Receiver operating characteristic curves identified cutoff values of the FSH and LH levels of 1.30 and 0.35 mIU/mL, respectively, for predicting ≥60% normal fertilization.

CONCLUSION

Gonadotropin levels at the start of COS are predictors of response to GnRHa trigger and hCG re-trigger necessity, and may serve as indicators to help clinicians appropriately choose hCG re-trigger rather than abandoning the cycles or continuing the first oocyte aspiration attempt.

摘要

目的

评估在控制性卵巢刺激(COS)周期中,对促性腺激素释放激素激动剂(GnRHa)触发反应不良的患者使用人绒毛膜促性腺激素(hCG)再次触发的适宜性。

方法

回顾性分析2013年至2018年间2251例接受GnRHa触发进行卵母细胞刺激的患者的2251个周期,这些患者无论是否需要hCG再次触发,比较COS开始时的促性腺激素水平以及再次触发组和未再次触发组之间的正常受精率。此外,将再次触发组的患者按正常受精率分层(良好:≥60%或不良:<60%),以比较亚组之间的患者人口统计学、激素谱和临床结局。

结果

在再次触发组中,良好受精组COS开始时的FSH和LH水平显著低于不良受精组(<0.01)。受试者工作特征曲线确定FSH和LH水平的截断值分别为1.30和0.35 mIU/mL,用于预测≥60%的正常受精。

结论

COS开始时的促性腺激素水平是对GnRHa触发反应和hCG再次触发必要性的预测指标,可作为帮助临床医生适当选择hCG再次触发而非放弃周期或继续首次卵母细胞抽吸尝试的指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d46a/7812458/5694ff5938fb/RMB2-20-96-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d46a/7812458/1607f30f1b35/RMB2-20-96-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d46a/7812458/30a1eb17287b/RMB2-20-96-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d46a/7812458/4e273df9e362/RMB2-20-96-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d46a/7812458/9c2689f3b1c9/RMB2-20-96-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d46a/7812458/5694ff5938fb/RMB2-20-96-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d46a/7812458/1607f30f1b35/RMB2-20-96-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d46a/7812458/30a1eb17287b/RMB2-20-96-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d46a/7812458/4e273df9e362/RMB2-20-96-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d46a/7812458/9c2689f3b1c9/RMB2-20-96-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d46a/7812458/5694ff5938fb/RMB2-20-96-g005.jpg

相似文献

1
Gonadotropin levels at the start of ovarian stimulation predict normal fertilization after hCG re-trigger in GnRH antagonist cycles.在GnRH拮抗剂周期中,卵巢刺激开始时的促性腺激素水平可预测hCG再次触发后的正常受精情况。
Reprod Med Biol. 2020 Dec 18;20(1):96-107. doi: 10.1002/rmb2.12359. eCollection 2021 Jan.
2
Dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves oocyte yield in normal responders on GnRH-antagonist cycles.促性腺激素释放激素激动剂和人绒毛膜促性腺激素双重触发可显著提高 GnRH 拮抗剂周期中正常反应者的卵子产量。
JBRA Assist Reprod. 2022 Jan 17;26(1):28-32. doi: 10.5935/1518-0557.20210039.
3
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.在拮抗剂辅助生殖技术中,促性腺激素释放激素激动剂与绒毛膜促性腺激素用于卵母细胞触发的比较
Cochrane Database Syst Rev. 2014 Oct 31;2014(10):CD008046. doi: 10.1002/14651858.CD008046.pub4.
4
GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.促性腺激素释放激素激动剂与绒毛膜促性腺激素触发在不同患者的体外受精/卵胞浆内单精子注射周期中的应用:一项回顾性研究。
J Obstet Gynaecol. 2020 Aug;40(6):837-842. doi: 10.1080/01443615.2019.1674262. Epub 2019 Dec 3.
5
Reproductive Outcome After GnRH Agonist Triggering With Co-Administration of 1500 IU hCG on the Day of Oocyte Retrieval in High Responders: A Long-Term Retrospective Cohort Study.在高反应者取卵日给予 1500IU hCG 联合 GnRH 激动剂触发后对妊娠结局的影响:一项长期回顾性队列研究。
Front Endocrinol (Lausanne). 2022 Apr 6;13:826411. doi: 10.3389/fendo.2022.826411. eCollection 2022.
6
Serum Gonadotropin Levels Predict Post-Trigger Luteinizing Hormone Response in Antagonist Controlled Ovarian Hyperstimulation Cycles.血清促性腺激素水平预测拮抗剂控制的卵巢超排卵周期中触发后黄体生成素反应。
Reprod Sci. 2023 Apr;30(4):1335-1342. doi: 10.1007/s43032-022-01105-8. Epub 2022 Oct 26.
7
Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.评估促性腺激素释放激素激动剂亮丙瑞林触发卵母细胞成熟的充分性和处理反应不足。
Fertil Steril. 2016 Oct;106(5):1093-1100.e3. doi: 10.1016/j.fertnstert.2016.06.013. Epub 2016 Jun 21.
8
Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.促性腺激素释放激素激动剂和人绒毛膜促性腺激素双重触发可显著提高 GnRH 拮抗剂周期中正常反应者的活产率。
Fertil Steril. 2013 Nov;100(5):1296-302. doi: 10.1016/j.fertnstert.2013.07.1976. Epub 2013 Aug 28.
9
Dual trigger with the combination of gonadotropin-releasing hormone agonist and standard dose of human chorionic gonadotropin improves fertilisation outcomes in poor ovarian responders.双重触发,即使用促性腺激素释放激素激动剂和人绒毛膜促性腺激素标准剂量的联合治疗,可以改善卵巢反应不良患者的受精结局。
J Obstet Gynaecol. 2022 Jul;42(5):1239-1244. doi: 10.1080/01443615.2021.1945560. Epub 2021 Sep 25.
10
Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle.GnRH 拮抗剂或灵活孕激素预处理卵巢刺激周期后 GnRH 激动剂触发的结局。
Front Endocrinol (Lausanne). 2022 May 19;13:837880. doi: 10.3389/fendo.2022.837880. eCollection 2022.

本文引用的文献

1
Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation.通过在卵巢刺激开始时测量血清 LH 预测 GnRH 激动剂触发后卵母细胞产量不佳。
Hum Reprod. 2019 Oct 2;34(10):2027-2035. doi: 10.1093/humrep/dez132.
2
Long-term outcomes of freeze-all strategy: A retrospective analysis from a single ART center in Japan.全胚冷冻策略的长期结局:来自日本一家辅助生殖技术中心的回顾性分析。
Reprod Med Biol. 2019 Jan 16;18(2):173-179. doi: 10.1002/rmb2.12264. eCollection 2019 Apr.
3
Empty Follicle Syndrome Following GnRHa Trigger in PCOS Patients Undergoing IVF Cycles.
多囊卵巢综合征患者在接受体外受精周期时使用促性腺激素释放激素激动剂扳机后出现空卵泡综合征
J Reprod Infertil. 2018 Jan-Mar;19(1):16-25.
4
Sliding scale HCG trigger yields equivalent pregnancy outcomes and reduces ovarian hyperstimulation syndrome: Analysis of 10,427 IVF-ICSI cycles.滑动剂量人绒毛膜促性腺激素扳机法产生等效的妊娠结局并降低卵巢过度刺激综合征:对10427个体外受精-卵胞浆内单精子注射周期的分析。
PLoS One. 2017 Apr 25;12(4):e0176019. doi: 10.1371/journal.pone.0176019. eCollection 2017.
5
Caffeine delays oocyte aging and maintains the quality of aged oocytes safely in mouse.咖啡因可延缓小鼠卵母细胞衰老,并安全维持老化卵母细胞的质量。
Oncotarget. 2017 Mar 28;8(13):20602-20611. doi: 10.18632/oncotarget.15292.
6
Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews.辅助生殖技术周期中预防卵巢过度刺激综合征的干预措施:Cochrane系统评价概述
Cochrane Database Syst Rev. 2017 Jan 23;1(1):CD012103. doi: 10.1002/14651858.CD012103.pub2.
7
Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.评估促性腺激素释放激素激动剂亮丙瑞林触发卵母细胞成熟的充分性和处理反应不足。
Fertil Steril. 2016 Oct;106(5):1093-1100.e3. doi: 10.1016/j.fertnstert.2016.06.013. Epub 2016 Jun 21.
8
Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles.体外受精周期中促性腺激素释放激素激动剂扳机反应欠佳的危险因素。
Fertil Steril. 2015 Sep;104(3):637-42. doi: 10.1016/j.fertnstert.2015.06.011. Epub 2015 Jul 3.
9
Maternal and neonatal outcomes after gonadotropin-releasing hormone agonist trigger for final oocyte maturation in patients undergoing in vitro fertilization.促性腺激素释放激素激动剂触发卵子成熟在体外受精患者中的母婴结局。
Fertil Steril. 2014 Sep;102(3):753-8. doi: 10.1016/j.fertnstert.2014.05.030. Epub 2014 Jun 19.
10
Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials.卡麦角林预防卵巢过度刺激综合征:随机对照试验的系统评价和荟萃分析。
Fertil Steril. 2014 Mar;101(3):664-75. doi: 10.1016/j.fertnstert.2013.11.005. Epub 2013 Dec 18.